poLight (PLT) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
31 Jan, 2026Executive summary
Achieved new design wins and product launches in AR/MR, barcode, and scientific imaging, with growing interest from major OEMs in TWedge technology and AF solutions.
Q1 2024 featured board changes, a successful rights issue raising NOK 124 million, and increased global presence.
AR/MR market is a key focus, with poLight's AF solution used in four commercial products and consumer-related activities maturing.
Industrial and scientific segments, including barcode and healthcare, continue to expand with new products, partnerships, and design wins.
Revenue declined year-over-year, but important milestones in product development and market expansion were achieved.
Financial highlights
Q1 2024 revenue was NOK 1.3 million, down from NOK 7.1 million in Q1 2023; EBITDA loss widened to NOK 18.8 million from NOK 14.0 million.
Cash and cash equivalents at quarter-end were NOK 95.3 million, down from NOK 114.8 million at year-end 2023, before share issue proceeds.
Net cash used in operating activities was NOK 19.2 million, improved from NOK 30.6 million in Q1 2023 due to no wafer purchases.
Gross margin was negative, reflecting low sales and increased inventory obsolescence provision.
Net loss for the period was NOK 20.5 million, with EPS at NOK -0.31.
Outlook and guidance
AR/MR market momentum continues, with poLight's AF solutions in four commercial products and strong OEM interest in TWedge.
Consumer market remains challenging, but actions to improve competitiveness and broaden smartphone applications are underway.
Industrial and scientific markets are expanding, with increasing product pipeline and new applications.
Cash runway extended into 2026 following the rights issue.
Latest events from poLight
- AR/MR and TWedge segments show strong momentum, with investments supporting future growth.PLT
Investor update2 Mar 2026 - Record Q4 revenue and strong AR/MR momentum, with 60% gross margin and robust cash reserves.PLT
Q4 202524 Feb 2026 - AR/MR and industrial momentum grows, cash up, smartphone market remains challenging.PLT
Q2 20241 Feb 2026 - AR/MR and consumer markets prioritized, with new tech and strong pipeline driving growth from 2026.PLT
CMD 202431 Jan 2026 - Revenue fell, but AR/MR and healthcare pipelines grew, backed by strong cash reserves.PLT
Q3 202417 Jan 2026 - Expanding in AR/MR and consumer markets, with strong tech and strategic customer engagement.PLT
Investor Update12 Jan 2026 - AR/MR and industrial segments show strong momentum, with robust financials and expanding PoCs.PLT
Investor Update26 Dec 2025 - Q1 2025 revenue climbed, losses widened, and Q Tech investment boosts AR/MR prospects.PLT
Q1 202523 Dec 2025 - Tunable lens tech gains traction in AR/MR, with strong consumer pipeline and strategic backing.PLT
ABGSC Investor Days4 Dec 2025